Over the past four decades, rare disease drug development has evolved from a scientific aspiration into a central pillar of biopharmaceutical innovation. Regulatory reforms, scientific breakthroughs, ...
Thank you very much, Francesca. 2024 was a strong year of execution and performance for Pfizer. Aamir Malik and Alexandre de ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results